2020 ROSENMAN INNOVATORS ivankornienko 1月, 2024 Nanotechnology Avisi Technologies is developing VisiPlate to treat glaucoma, the world’s leading cause of irreversible blindness. VisiPlate is a nanotechnology-enabled ocular implant for treating glaucoma more safely and effectively. Share this article:
PENNTODAY Each student’s unique perspective, such as Jiang’s experience working in pharmaceutical companies, Kao’s knowledge of materials science engineering, and Battu’s understanding of need-finding through past startup experience, allowed them to take a very research-focused view to leverage this novel nanotechnology in the human body.
Where Ideas Come to Life After Rui Jing Jiang W18 and her team, Avisi Technologies won the 2017 Y-Prize technology contest with their idea — an ultra-thin drainage implant, called VisiPlate, to treat glaucoma — they moved through two university accelerators and developed their product through a Penn Engineering lab and the Singh Center for Nanotechnology. “We met a ton of entrepreneurs by just being at Penn, and it fostered a sense of community,” says Jiang. “Being able to get to where we are today is testament to the incredible nature of the technology that was spun out of Penn.”
48 Most Promising Nanotechnology Startups with Seed Funding (US) At Just Funded Media we track over 1,000,000 recently funded startups and over 3,800,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and organisations we think deserve more appreciation than they are currently getting.